95 filings
6-K
PHXM
PHAXIAM Therapeutics S.A.
21 Feb 24
PHAXIAM Therapeutics announces intention to voluntary delist American Depositary Shares from The Nasdaq Capital Market
6:05am
6-K
PHXM
PHAXIAM Therapeutics S.A.
19 Jan 24
PHAXIAM Therapeutics announces its cash position at the end of 2023 and its financial calendar for 2024
10:04am
6-K
PHXM
PHAXIAM Therapeutics S.A.
16 Nov 23
PHAXIAM Provides Business and Financial Update
7:41am
6-K
PHXM
PHAXIAM Therapeutics S.A.
25 Oct 23
Current report (foreign)
9:21am
6-K
PHXM
PHAXIAM Therapeutics S.A.
11 Oct 23
PHAXIAM Therapeutics announces high coverage performance of its two anti-Staphylococcus aureus phages over clinical strains
6:53am
6-K
9h8umaud
5 Oct 23
PHAXIAM Therapeutics and Vetophage Announce
7:32am
6-K
rx6b10t nefjq
26 Sep 23
I.Certification of the Person Responsible for the Half-year Financial Report
3:01pm
6-K
7x9pl
21 Sep 23
Current report (foreign)
8:42am
6-K
fz7wyf8
18 Sep 23
PHAXIAM Therapeutics announces the completion of its reverse share split
8:16am
6-K
hppn77c jx8
15 Sep 23
Current report (foreign)
8:03am
6-K
88h 0jbvql12x6v
7 Sep 23
PHAXIAM Therapeutics publishes its cash position and new financial calendar, and announces its participation at upcoming investor conferences
9:33am
6-K
83lxj vnxtsm0qt
27 Jul 23
PHAXIAM Therapeutics announces a reverse share split of
4:21pm
6-K
6cw0xwjgebdr sdig
30 Jun 23
Current report (foreign)
11:33am
6-K
smhse
28 Jun 23
Current report (foreign)
8:53am
6-K
pcy0 9zv1h
21 Jun 23
ERYTECH announces that Akkadian is continuing its attempt at destabilization with the filing of a new lawsuit
6:09am
6-K
gz3 zx6w7sh8p5
15 Jun 23
ERYTECH announces that the Commercial Court has rejected Akkadian's request to postpone the vote on the merger with Pherecydes Pharma
7:32am
6-K
737ny9b2qfo04g
12 Jun 23
Current report (foreign)
10:33am
6-K
6xst11990twt3c
6 Jun 23
ERYTECH announces that Akkadian has initiated proceedings to postpone the vote on the merger with Pherecydes
7:29am
6-K
cxkhb6bvpm1jwo
26 May 23
Current report (foreign)
7:39am
6-K
umigouub
24 May 23
Exemption Document Prepared In Connection with the Merger by Absorption of Pherecydes Pharma by Erytech Pharma
8:25am